Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Blood Preparation Market by Type (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Blood Preparation Market by Type (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 301821 4200 Pharma & Healthcare 377 148 Pages 4.9 (38)
                                          

Market Overview:


The global blood preparation market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of thrombocytosis, pulmonary embolism, renal impairment, and angina blood vessel complications. Additionally, the increasing demand for blood derivatives such as albumin and erythropoietin is also contributing to the growth of this market. However, stringent regulatory norms and reimbursement policies are restraining the growth of this market. On the basis of type, whole blood accounted for majority share in 2017 and is expected to maintain its dominance during forecast period 2018-2030 owing to its high usage rates across various applications such as thrombocytosis, pulmonary embolism, renal impairment etcetera.


Global Blood Preparation Industry Outlook


Product Definition:


A blood preparation is a substance that is derived from blood. It can be used to treat medical conditions or to improve the function of the body.


Whole Blood:


Whole blood is the complete blood from a human donor. It contains RBCs, WBCs and platelets. The main function of whole blood is to provide red cells for bleeding and white cells for immunization against bacteria or viruses. Whole Blood also provides stem cell factor which helps in healing wounds quickly by producing new skin, bones & tissue; however; this property can be achieved with the help of other growth factors as well.


Blood Components:


Blood components are the parts of blood that are collected from a person for transfusion or autologous donation. The most common types of blood components include red cells, white cells, platelets and plasma. These products have different functions in terms of their therapeutic applications and this has led to extensive research in order to develop novel therapies for various diseases.


Application Insights:


The others application segment held the largest share of the global blood preparation market in 2017. This is due to an increase in surgeries that require a large number of blood products. For instance, as per the National Center for Biotechnology Information (NCBI) in 2016, around 20 million units of red cells and 40 million units of platelets are required annually for stem cell therapy procedures globally. Therefore, demand for these products will remain high even after 2020 when new product launches would be completed.


North America will witness growth owing to an increase in healthcare expenditure by U.S government and private organizations such as Merck & Co., Inc.


Regional Analysis:


North America dominated the global blood preparation market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing R&D activities for the development of novel products are some factors responsible for its large share. Moreover, growing number of patients suffering from chronic diseases such as cancer and diabetes is also expected to drive this regional market over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism in emerging countries such as China and India. In addition, rapidly developing healthcare infrastructure coupled with increasing patient awareness levels regarding blood donation will support regional growth during the estimated time span. Europe accounted for a significant revenue share in 2017 due to high incidence rates of cardiovascular disorders among consumers there compared with North America region (approximately 1% higher). This factor will further boost demand over coming years ( 2030).


Growth Factors:


  • Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyles and dietary habits of people. The rise in the number of patients with chronic diseases will lead to an increase in demand for blood preparations, as these products are used for treatment purposes.
  • Technological advancements: Blood preparation products are witnessing rapid technological advancements, which is resulting in improved efficacy and safety profiles. This is likely to boost demand for these products in the coming years.
  • Growing awareness about blood transfusions: There is a growing awareness among people about blood transfusions and their benefits. This has led to an increase in demand for blood preparations worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Blood Preparation Market Research Report

By Type

Whole Blood, Blood Components, Blood Derivatives

By Application

Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others

By Companies

GlaxoSmithKline, Baxter Healthcare Corp, Pfizer, Bristol-Myers Squibb Company, Sanofi Aventis, AstraZeneca, Celgene Corporation, Leo Pharma, GlaxoSmithKline

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

148

Number of Tables & Figures

104

Customization Available

Yes, the report can be customized as per your need.


Global Blood Preparation Market Report Segments:

The global Blood Preparation market is segmented on the basis of:

Types

Whole Blood, Blood Components, Blood Derivatives

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GlaxoSmithKline
  2. Baxter Healthcare Corp
  3. Pfizer
  4. Bristol-Myers Squibb Company
  5. Sanofi Aventis
  6. AstraZeneca
  7. Celgene Corporation
  8. Leo Pharma
  9. GlaxoSmithKline

Global Blood Preparation Market Overview


Highlights of The Blood Preparation Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Whole Blood
    2. Blood Components
    3. Blood Derivatives
  1. By Application:

    1. Thrombocytosis
    2. Pulmonary Embolism
    3. Renal Impairment
    4. Angina Blood Vessel Complications
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Blood Preparation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Blood Preparation Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Blood preparation is the process of cleaning and separating blood cells from other bodily fluids. This is done to make it easier to transfuse blood into a patient.

Some of the key players operating in the blood preparation market are GlaxoSmithKline, Baxter Healthcare Corp, Pfizer, Bristol-Myers Squibb Company, Sanofi Aventis, AstraZeneca, Celgene Corporation, Leo Pharma, GlaxoSmithKline.

The blood preparation market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Preparation Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Blood Preparation Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Blood Preparation Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Blood Preparation Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Blood Preparation Market Size & Forecast, 2018-2028       4.5.1 Blood Preparation Market Size and Y-o-Y Growth       4.5.2 Blood Preparation Market Absolute $ Opportunity

Chapter 5 Global Blood Preparation Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Blood Preparation Market Size Forecast by Type
      5.2.1 Whole Blood
      5.2.2 Blood Components
      5.2.3 Blood Derivatives
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Blood Preparation Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Blood Preparation Market Size Forecast by Applications
      6.2.1 Thrombocytosis
      6.2.2 Pulmonary Embolism
      6.2.3 Renal Impairment
      6.2.4 Angina Blood Vessel Complications
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Blood Preparation Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Blood Preparation Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Blood Preparation Analysis and Forecast
   9.1 Introduction
   9.2 North America Blood Preparation Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Blood Preparation Market Size Forecast by Type
      9.6.1 Whole Blood
      9.6.2 Blood Components
      9.6.3 Blood Derivatives
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Blood Preparation Market Size Forecast by Applications
      9.10.1 Thrombocytosis
      9.10.2 Pulmonary Embolism
      9.10.3 Renal Impairment
      9.10.4 Angina Blood Vessel Complications
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Blood Preparation Analysis and Forecast
   10.1 Introduction
   10.2 Europe Blood Preparation Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Blood Preparation Market Size Forecast by Type
      10.6.1 Whole Blood
      10.6.2 Blood Components
      10.6.3 Blood Derivatives
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Blood Preparation Market Size Forecast by Applications
      10.10.1 Thrombocytosis
      10.10.2 Pulmonary Embolism
      10.10.3 Renal Impairment
      10.10.4 Angina Blood Vessel Complications
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Blood Preparation Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Blood Preparation Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Blood Preparation Market Size Forecast by Type
      11.6.1 Whole Blood
      11.6.2 Blood Components
      11.6.3 Blood Derivatives
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Blood Preparation Market Size Forecast by Applications
      11.10.1 Thrombocytosis
      11.10.2 Pulmonary Embolism
      11.10.3 Renal Impairment
      11.10.4 Angina Blood Vessel Complications
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Blood Preparation Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Blood Preparation Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Blood Preparation Market Size Forecast by Type
      12.6.1 Whole Blood
      12.6.2 Blood Components
      12.6.3 Blood Derivatives
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Blood Preparation Market Size Forecast by Applications
      12.10.1 Thrombocytosis
      12.10.2 Pulmonary Embolism
      12.10.3 Renal Impairment
      12.10.4 Angina Blood Vessel Complications
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Blood Preparation Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Blood Preparation Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Blood Preparation Market Size Forecast by Type
      13.6.1 Whole Blood
      13.6.2 Blood Components
      13.6.3 Blood Derivatives
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Blood Preparation Market Size Forecast by Applications
      13.10.1 Thrombocytosis
      13.10.2 Pulmonary Embolism
      13.10.3 Renal Impairment
      13.10.4 Angina Blood Vessel Complications
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Blood Preparation Market: Competitive Dashboard
   14.2 Global Blood Preparation Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 GlaxoSmithKline
      14.3.2 Baxter Healthcare Corp
      14.3.3 Pfizer
      14.3.4 Bristol-Myers Squibb Company
      14.3.5 Sanofi Aventis
      14.3.6 AstraZeneca
      14.3.7 Celgene Corporation
      14.3.8 Leo Pharma
      14.3.9 GlaxoSmithKline

Our Trusted Clients

Contact Us